Acceder

Publicaciones - Terapias moleculares y biomarcadores de tumores sólidos

Cargando...
Chauvistre H, Shannan B, Daignault-Mill SM, Ju RJ, Picard D, Egetemaier S, Varaljai R, Gibhardt CS, Sechi A, Kaschani F, Keminer O, Stehbens SJ, Liu Q, Yin X, Jeyakumar K, Vogel FCE, Krepler C, Rebecca VW, Kubat L, Lueong SS, Forster J, Horn S, Remke M, Ehrmann M, Paschen A, Becker JC, Helfrich I, Rauh D, Kaiser M, Gul S, Herlyn M, Bogeski I, Rodriguez-Lopez JN, Haass NK, Schadendorf D, Roesch A. Persister state-directed transitioning and vulnerability in melanoma. Nat Commun. 2022 Jun 1;13(1):3055. doi: 10.1038/s41467-022-30641-9. PubMed PMID: 35650266; PubMed Central PMCID: PMC9160289.
AÑO: 2022; IF: 17.694
Garcia-Molina P, Garcia-Molina F, Teruel-Puche JA, Rodriguez-Lopez JN, Garcia-Canovas F, Munoz-Munoz JL. The Relationship between the IC50 Values and the Apparent Inhibition Constant in the Study of Inhibitors of Tyrosinase Diphenolase Activity Helps Confirm the Mechanism of Inhibition. Molecules. 2022 May 13;27(10):3141. doi: 10.3390/molecules27103141. PubMed PMID: 35630619; PubMed Central PMCID: PMC9142954.
AÑO: 2022; IF: 4.927
Piñero-Madrona A, Nicolás-Ruiz F, Rull-Ortuño R, Vidal-Sicart S, Cabañas-Montero J, Rioja-Martín ME, Rodríguez-Fernández R, Gil-Olarte MÁ, González-García B, Sánchez JH. Correlation between ferromagnetic and isotopic tracers for sentinel lymph node detection in cutaneous melanoma: IMINEM study. J Surg Oncol. 2021 Feb;123(2):654-659. doi: 10.1002/jso.26303. Epub 2020 Nov 25. PubMed PMID: 33238054.
AÑO: 2021; IF: 2.885
Matías-Sánchez M, Oviedo-Ramírez MI, Díaz-Manzano JA. Polymethylmethacrylate Granuloma After Septoplasty. Acta Otorrinolaringol Esp (Engl Ed). 2021 Sep-Oct;72(5):329-331. doi: 10.1016/j.otoeng.2021.07.002. PubMed PMID: 34535224.
AÑO: 2021
García-Molina P, Muñoz-Muñoz JL, Rodríguez-López JN, García-Cánovas F, García-Molina F. Selection of most powerful depigmenting agents: Considerations about their possible use. Dermatol Ther. 2021 Mar;34(2):e14774. doi: 10.1111/dth.14774. Epub 2021 Jan 17. PubMed PMID: 33426740.
AÑO: 2021; IF: 3.858
Siguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII

Terapias moleculares y biomarcadores de tumores sólidos